Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Impairment of lung aconitase activity, citric acid cycle, and mitochondrial respiration by
hyperoxia
necessitates the elevation of glycolysis for energy production and of pentose shunt activity for reducing equivalents. The molecular mechanisms that allow increased glucose utilization are unknown. Adult male and female rats were adapted to sublethal
hyperoxia
, equivalent to 83% oxygen at sea level, or air for 7 days. Lung RNA and protein increased in
hyperoxia
(197 and 57%, respectively), whereas total DNA was unchanged. In
hyperoxia
, lung total hexokinase (HK) activity increased threefold, and mRNAs for HK-II and -III were specifically upregulated. HK-I mRNA was unchanged. mRNAs for HK-II and -III gradually increased during the first 72 h in
hyperoxia
. HK-II mRNA was significantly elevated at 72 h, preceding changes in lung cell populations. Although virtually absent in air, HK-II activity was highly expressed in
hyperoxia
. Among lung glucose transporters, specific expression of mRNAs for GLUT-4 (insulin dependent) and
sodium-glucose cotransporter
-1 was decreased, whereas that for GLUT-1 was minimally changed. Adaptation to
hyperoxia
involves coordinated changes in gene expression for the proteins regulating pulmonary glucose transport.
...
PMID:Changes in pulmonary expression of hexokinase and glucose transporter mRNAs in rats adapted to hyperoxia. 953 Jan 66